Title |
A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies
|
---|---|
Published in |
Annals of Surgical Oncology, March 2014
|
DOI | 10.1245/s10434-014-3602-0 |
Pubmed ID | |
Authors |
Freya Schnabel, Susan K. Boolbol, Mark Gittleman, Tami Karni, Lorraine Tafra, Sheldon Feldman, Alice Police, Neil B. Friedman, Scott Karlan, Dennis Holmes, Shawna C. Willey, Moshe Carmon, Kristen Fernandez, Stephanie Akbari, Jay Harness, Lisa Guerra, Thomas Frazier, Karen Lane, Rache M. Simmons, Alison Estabrook, Tanir Allweis |
Abstract |
The presence of tumor cells at the margins of breast lumpectomy specimens is associated with an increased risk of ipsilateral tumor recurrence. Twenty to 30 % of patients undergoing breast-conserving surgery require second procedures to achieve negative margins. This study evaluated the adjunctive use of the MarginProbe device (Dune Medical Devices Ltd, Caesarea, Israel) in providing real-time intraoperative assessment of lumpectomy margins. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Canada | 1 | <1% |
Unknown | 126 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 16% |
Student > Ph. D. Student | 16 | 13% |
Student > Master | 16 | 13% |
Student > Bachelor | 10 | 8% |
Student > Doctoral Student | 9 | 7% |
Other | 25 | 20% |
Unknown | 32 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 33% |
Engineering | 19 | 15% |
Agricultural and Biological Sciences | 6 | 5% |
Physics and Astronomy | 6 | 5% |
Biochemistry, Genetics and Molecular Biology | 4 | 3% |
Other | 17 | 13% |
Unknown | 34 | 27% |